Americans preparing to enroll in 2026 Affordable Care Act (ACA) health insurance plans are facing steep premium hikes, with monthly costs expected to more than double on average. The sharp rise stems from the expiration of COVID-19 pandemic-era subsidies that have been central to the ongoing U.S. government shutdown. These subsidies, which boosted enrollment to a record 24 million since 2021, are set to expire at the end of the year, potentially increasing the number of uninsured Americans and influencing election outcomes.
According to health research firm KFF, ACA enrollees will see average premiums rise by 114%. While 22 million people currently receive subsidies, the impact will vary widely. For example, 24-year-old Californian Austin Jeha’s monthly premium is expected to jump from $215 to $436. Like many, he relies on his ACA plan for essential medical care and is urging Congress to extend the subsidies.
The budget impasse in Washington has left much of the government shuttered since October 1. Democrats are pushing to include ACA funding in any reopening deal, while Republicans insist on restoring government funding first. Residents of Republican-led states such as Florida, Texas, and Georgia are expected to be hit hardest, as limited Medicaid coverage forces many low-income workers to depend on ACA plans.
If subsidies expire, households earning just above 400% of the federal poverty line—around $84,600 for a couple—could see their premiums quadruple. Experts warn enrollment will decline even if subsidies are later reinstated, as consumers may abandon plans after seeing higher rates. The Congressional Budget Office estimates over 4 million Americans could lose coverage without renewed tax credits. Rising healthcare costs and insurer exits, such as CVS Health’s Aetna leaving the ACA market, have already driven a 26% increase in premiums. For many families, healthcare remains essential but increasingly unaffordable.


Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
FDA Approves Mitapivat for Anemia in Thalassemia Patients
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Japan Election 2026: Sanae Takaichi Poised for Landslide Win Despite Record Snowfall
Pentagon Ends Military Education Programs With Harvard University
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
US Pushes Ukraine-Russia Peace Talks Before Summer Amid Escalating Attacks
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Paul Atkins Emphasizes Global Regulatory Cooperation at Fintech Conference
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 



